UTHR - United Therapeutics Q3 2023 Earnings Preview
2023-10-31 12:39:29 ET
More on United Therapeutics
- United Therapeutics Shifts Focus To Tyvaso DPI Amidst Generic Threat
- United Therapeutics: Both Fundamental And Technical Analyses Justify A Buy Decision
- United Therapeutics: Eyeing A Re-Rating To 12-13x P/E, Growth More Than Justified
- United Therapeutics to buy Miromatrix Medical for $3.25 per share, MIRO jumps 225%
- Liquidia gains as court sets December date for hearing in patent dispute
For further details see:
United Therapeutics Q3 2023 Earnings Preview